7th Annual Cedars-Sinai Virtual Medicine Conference (vMed 25)

Thursday, March 27, 2025, 8:00 AM - Friday, March 28, 2025, 4:00 PM PST, Sofitel Los Angeles at Beverly Hills, 8555 Beverly Boulevard, Los Angeles, CA


For decades, scientists have been quietly discovering the surprising health benefits of virtual reality (V for ailments ranging from burn injuries, to stroke, to PTSD, to schizophrenia. Over ten thousand studies reveal that VR has an uncanny ability to calm pain, steady nerves, and boost mental health. VR is helping to deliver babies, enabling soldiers to cope with the mental scars of war, and reminding doctors that patients are not broken machines, but are people whose lives matter. VR is not just for gamers anymore; it is a new type of mind-body medicine. Cedars-Sinai Virtual Medicine is a multidisciplinary program dedicated to harnessing the power of MXR technologies, including virtual reality (VR), augmented reality (AR) and mixed reality (MR), to develop and test innovative virtual therapeutics. Developed by the Cedars-Sinai Virtual Medicine program with generous support from the Marc and Sheri Rapaport Fund for Digital Health Sciences and Precision Health, the annual Virtual Medicine (vMed) Conference is a two-day symposium that convenes the brightest minds in Medical Extended Reality (MXR). Participants learn from case studies, didactic lectures, and patient vignettes to achieve the following educational objectives: 1. Learn best practices and pragmatic tips for implementing MXR into clinical practice. 2. Review evidence supporting the efficacy of MXR applications for patient care. 3. Discuss the cost-effectiveness, payer perspectives, and regulatory landscape of MXR 4. Hear from patients who have received MXR therapeutics. 5. Study uses of MXR for clinical simulation and provider training.

1. Review best practices and pragmatic tips for implementing MXR into clinical practice.
2. Review evidence supporting the efficacy of MXR applications for patient care.
3. Discuss the costeffectiveness, payer perspectives, and regulatory landscape of MXR.
4. Interact and hear from patients who have received MXR therapeutics.
5. Study uses of MXR for clinical simulation and provider training.

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement
Cedars-Sinai designates this Live Activity for a maximum of 14.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician AMA Attendance
Attendance credit will be provided to other healthcare professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.  

AMA PRA Category 1 Credit(s)™ (MD, DO) (13.50 hours), Non-Physician AMA Attendance (13.50 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.